Literature DB >> 6789022

Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid).

J Grove, P J Schechter, G Tell, J Koch-Weser, A Sjoerdsma, J M Warter, C Marescaux, L Rumbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6789022     DOI： 10.1016/0024-3205(81)90511-7

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  26 in total

1.  Passage of S(+) and R(-) gamma-vinyl-GABA across the human isolated perfused placenta.

Authors:  J C Challier; E Rey; T Bintein; G Olive
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

Review 2.  Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.

Authors:  P J Schechter; A Sjoerdsma
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

Review 3.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Effect of gamma aminobutyric acid on the carbon dioxide rebreathing response of normal subjects: a study using vigabatrin.

Authors:  A G Fennerty; E M Rimmer; J Boulton; A Richens
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

Review 5.  Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.

Authors:  O A Petroff; D L Rothman
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

Review 6.  Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.

Authors:  T A Hare
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

7.  Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug.

Authors:  E Rimmer; G Kongola; A Richens
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

8.  Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies.

Authors:  Mahsa Parviz; Kara Vogel; K Michael Gibson; Phillip L Pearl
Journal:  J Pediatr Epilepsy       Date:  2014-11-25

9.  Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses.

Authors:  E Toth; A Lajtha
Journal:  Neurochem Res       Date:  1981-12       Impact factor: 3.996

Review 10.  Clinical pharmacology of vigabatrin.

Authors:  P J Schechter
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.